Feed/Companies/Setara Biosciences

Setara Biosciences

As of 30 Oct 2026, Setara Biosciences has raised $90M across 1 verified round on record; latest: $90 million Series A, announced 30 Oct 2026.

A clinical-stage rare disease biotech formed by Actio Biosciences alums

Biotech

LATEST ROUND

Series A

$90M · 2026-10-30

RAISED ON RECORD · USD

$90M

across 1 verified round

INVESTORS

no lead named

SOURCES

from 4 publishers

Rounds

[ 1 ]

Series A

$90M ·

Every round on record, with the sources behind each and the investors on them.

Round	Amount	Announced	Lead	Buzz
Series A	$90M	2026-10-30	not stated	4 outlets. #56 in Trending
4 sources [ VERIFIED · CORRECTED ] read against 4 sources Source 3 says the company’s post-financing valuation was not disclosed. [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]4 pages read: businesswire.com, amp.axios.com, axios.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 4 sources